Profusa, Inc.
PFSANasdaqCIK 1859807HealthcareFiscal year ends Dec 31
Reports and events: 123 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1506:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-109558 |
| 2026-10-0917:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-108552 |
| 2026-10-0506:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-106610 |
| 2026-09-2120:23 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-101568 |
| 2026-09-1606:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-100304 |
| 2026-09-1506:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099871 |
| 2026-09-0108:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-095984 |
| 2026-08-3108:54 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-095405 |
| 2026-08-2816:30 ET | DEF 14A | Proxy statementPeriod 2026-09-18 | 0001213900-26-095087 |
| 2026-08-2116:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-092597 |
| 2026-08-2008:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-091905 |
| 2026-08-1920:14 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-091840 |
| 2026-08-1916:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-091696 |
| 2026-08-1420:42 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-089362 |
| 2026-07-3116:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-084064 |
| 2026-07-2706:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-081560 |
| 2026-07-0616:16 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-075502 |
| 2026-06-2313:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-070970 |
| 2026-06-0807:01 ET | 8-K | 8.01 Other events | 0001213900-26-066018 |
| 2026-05-2612:35 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001213900-26-060916 |
| 2026-05-2611:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-060879 |
| 2026-05-1817:29 ET | 8-K | 8.01 Other events | 0001213900-26-058575 |
| 2026-05-1516:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057887 |
| 2026-05-1508:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-057182 |
| 2026-05-0806:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-053535 |
| 2026-05-0115:28 ET | S-1/A | Registration statement, amended | 0001213900-26-050904 |
| 2026-04-2917:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-26-049432 |
| 2026-04-2808:19 ET | S-1 | Registration statement | 0001213900-26-048288 |
| 2026-04-2716:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048039 |
| 2026-04-2416:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-047578 |
| 2026-04-1516:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-044046 |
| 2026-04-0606:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-040111 |
| 2026-03-2616:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-034706 |
| 2026-03-1321:29 ET | 8-K | 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-027218 |
| 2026-02-1708:50 ET | S-1/A | Registration statement, amended | 0001213900-26-016936 |
| 2026-02-1316:41 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-016496 |
| 2026-02-1316:28 ET | S-1/A | Registration statement, amended | 0001213900-26-016447 |
| 2026-02-1312:49 ET | S-1 | Registration statement | 0001213900-26-016096 |
| 2026-02-0508:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-012552 |
| 2026-02-0420:06 ET | S-1 | Registration statement | 0001213900-26-011709 |
| 2026-02-0216:30 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-010808 |
| 2026-01-0206:09 ET | DEF 14A | Proxy statementPeriod 2026-01-27 | 0001213900-26-000004 |
| 2025-12-3007:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-126316 |
| 2025-12-2306:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-124826 |
| 2025-11-2018:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112761 |
| 2025-11-1917:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-112723 |
| 2025-11-0319:52 ET | 8-K | 3.01 Delisting notice | 0001213900-25-104814 |
| 2025-10-3007:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-103772 |
| 2025-10-2120:32 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-100494 |
| 2025-10-2117:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-100443 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.